CAAP1

Chr 9

caspase activity and apoptosis inhibitor 1

Also known as: C9orf82, CAAP

Involved in negative regulation of apoptotic process. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
4
Pubs (1 yr)
P/LP submissions
P/LP missense
0.46
LOEUF
LOF
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.46LOEUF
pLI 0.784
Z-score 2.95
OE 0.14 (0.060.46)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.47Z-score
OE missense 1.10 (0.981.23)
207 obs / 188.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.14 (0.060.46)
00.351.4
Missense OE?1.10 (0.981.23)
00.61.4
Synonymous OE?1.30
01.21.6
LoF obs/exp: 2 / 13.8Missense obs/exp: 207 / 188.7Syn Z: -1.99

ClinVar

No ClinVar data available.

Protein Context — Lollipop Plot

CAAP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →